Jinshi Asian Pharmaceutical

Jinshi Asian Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the research, development, manufacture, and sale of over-the-counter (OTC) and prescription medicines. The company is best known for its flagship cold and flu medication, 'Kuake', which has a significant market share in China. Beyond respiratory treatments, its product portfolio includes gastrointestinal medicines, cardiovascular drugs, and health supplements. Jinshi Asian Pharmaceutical operates several large-scale manufacturing bases and maintains a robust distribution network across mainland China. The company is publicly traded on the Shenzhen Stock Exchange and continues to expand its presence in the healthcare sector through both internal R&D and strategic acquisitions.